Enter assignee name

% Expired Patents = 20.0

CIPO Patents = 1

EPO Patents = 7

Forward Citations = 20

Loading Chart...

9 inventors (with patents filed for the assignee):

David Lawson Morris (9 out of 24 patents)

Roger Aston (7 out of 9 patents)

Mohammad Hossein Pourgholami (5 out of 5 patents)

4. Nobuharu Andoh (3 out of 7 patents)

5. Osamu Sanpei (3 out of 6 patents)

6. Tetsuo Toga (3 out of 3 patents)

7. Tomokazu Hino (3 out of 7 patents)

8. Koji Tanaka (3 out of 26 patents)

9. Richard Mollard (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12213957 - Use of aminoacetonitrile compounds for the treatment of infection and disease (2025-02-04),

2. 10391076 - Anti-cancer agent comprising aminoacetonitrile compound as active ingredient (2019-08-27),

3. 10292960 - Anticancer agent comprising aminoacetonitrile compound as active ingredient (2019-05-21),

4. 10053422 - Compounds for the treatment of mTOR pathway related diseases (2018-08-21),

5. 9907778 - Anticancer agent comprising aminoacetonitrile compound as active ingredient (2018-03-06),

6. 9833431 - Pharmaceutical combinations for the treatment of cancer (2017-12-05),

7. 9790176 - Compounds for the treatment of mTOR pathway related diseases (2017-10-17),

8. 9308193 - Kinase inhibitors for the treatment of cancer (2016-04-12),

9. 8912225 - VEGF inhibition (2014-12-16),

10. 8835478 - Treatment for cancer (2014-09-16),

Pitney Pharmaceuticals Pty Limited is a leading pharmaceutical company dedicated to developing innovative healthcare solutions. With a focus on research and development, we strive to improve the quality of life for patients worldwide. Our diverse product portfolio includes a range of prescription and over-the-counter medications, as well as cutting-edge medical devices. At Pitney Pharmaceuticals, we are committed to excellence in everything we do, from drug discovery to clinical trials to manufacturing and distribution.

Profile summary based on public USPTO records.